A detailed history of Truist Financial Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 17,788 shares of FOLD stock, worth $170,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,788
Previous 19,023 6.49%
Holding current value
$170,409
Previous $203,000 17.73%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$9.36 - $12.01 $11,559 - $14,832
-1,235 Reduced 6.49%
17,788 $167,000
Q3 2024

Nov 13, 2024

BUY
$9.55 - $12.09 $43,548 - $55,130
4,560 Added 31.53%
19,023 $203,000
Q2 2024

Aug 20, 2024

BUY
$9.04 - $11.75 $1,509 - $1,962
167 Added 1.17%
14,463 $143,000
Q1 2024

May 10, 2024

BUY
$11.43 - $14.24 $163,403 - $203,575
14,296 New
14,296 $168,000
Q4 2020

Feb 18, 2021

BUY
$13.47 - $24.89 $316,935 - $585,636
23,529 New
23,529 $543,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.